Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.
暂无分享,去创建一个
M. Buntin | T. Jones | Timothy F Jones | S. Patrick | Stephen W Patrick | Carrie E Fry | Melinda B Buntin | Carrie E. Fry | T. Jones | Melinda Buntin
[1] Thomas R Frieden,et al. Medication-assisted therapies--tackling the opioid-overdose epidemic. , 2014, The New England journal of medicine.
[2] Rose A Rudd,et al. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. , 2016, MMWR. Morbidity and mortality weekly report.
[3] K. Murray,et al. Out-of-hospital mortality among patients receiving methadone for noncancer pain. , 2015, JAMA internal medicine.
[4] Matthew M Davis,et al. Erratum: Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 (Journal of Perinatology (2015) 35 (667)) doi:10.1038/jp.2015.63 , 2015 .
[5] Dennis McCarty,et al. Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions. , 2013, Health affairs.
[6] Kun Zhang,et al. Prescription Practices involving Opioid Analgesics among Americans with Medicaid, 2010 , 2015, Journal of health care for the poor and underserved.
[7] E. Quinn,et al. Overdose Education and Naloxone Rescue Kits for Family Members of Individuals who Use Opioids: Characteristics, Motivations, and Naloxone Use , 2015, Substance abuse.
[8] Tamara M Haegerich,et al. What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. , 2014, Drug and alcohol dependence.
[9] E. Vuori,et al. Personally prescribed psychoactive drugs in overdose deaths among drug abusers: a retrospective register study. , 2015, Drug and alcohol review.
[10] P. DasMahapatra,et al. Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation. , 2014, Pain medicine.
[11] F. Harrell,et al. Prescription Opioid Epidemic and Infant Outcomes , 2015, Pediatrics.
[12] Leonard J. Paulozzi,et al. Vital Signs: Variation Among States in Prescribing of Opioid Pain Relievers and Benzodiazepines — United States, 2012 , 2014, MMWR. Morbidity and mortality weekly report.
[13] Lainie Rutkow,et al. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. , 2015, Health affairs.
[14] Erin M. Johnson,et al. Risk factors for prescription opioid-related death, Utah, 2008-2009. , 2012, Pain medicine.
[15] S. Cole,et al. Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies , 2009, Epidemiology.
[16] J. McAllister,et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. , 2012, JAMA.
[17] C. Cunningham,et al. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. , 2014, JAMA internal medicine.
[18] L. Paulozzi,et al. Opioid analgesics and rates of fatal drug poisoning in the United States. , 2006, American journal of preventive medicine.
[19] Daniel W Webster,et al. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. , 2015, JAMA internal medicine.
[20] Leonard J Paulozzi,et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.
[21] Leonard J Paulozzi,et al. Prescription drug monitoring programs and death rates from drug overdose. , 2011, Pain medicine.
[22] Karin A Mack,et al. Pharmaceutical overdose deaths, United States, 2010. , 2013, JAMA.
[23] Kelly Cho,et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. , 2015, JAMA internal medicine.
[24] L. Paulozzi,et al. Decline in Drug Overdose Deaths After State Policy Changes — Florida, 2010–2012 , 2014, MMWR. Morbidity and mortality weekly report.